Therapeutic siRNA silencing in inflammatory monocytes in mice
Florian Leuschner(Heidelberg University), Matthias Nahrendorf(Massachusetts General Hospital), Tatiana I. Novobrantseva(Alnylam Pharmaceuticals (United States)), Andita Newton(Harvard University), Yoshiko Iwamoto(Harvard University), Kang Mi Lee(Harvard University), Virna Cortez‐Retamozo(Vrije Universiteit Brussel), Filip K. Świrski(Allen Institute for Brain Science), Daniel G. Anderson(Massachusetts Institute of Technology), Kevin T. Love(Massachusetts Institute of Technology), Róbert Langer(Massachusetts Institute of Technology), Peter Libby(Harvard University), Hila Epstein-Barash(Alnylam Pharmaceuticals (United States)), Ralph Weissleder(Massachusetts General Hospital), James F. Markmann(University of Pennsylvania), Peter Panizzi(Harvard University), James I. Kim(Montreal Neurological Institute and Hospital), Gabriel Courties(Harvard University), Rostic Gorbatov(Harvard University), Jessica Donahoe(Center for Systems Biology), Stuart Milstein(Alnylam Pharmaceuticals (United States)), Won Woo Lee(Seoul National University Bundang Hospital), William Cantley(Alnylam Pharmaceuticals (United States)), Partha Dutta(Harvard University), Victor Koteliansky(Centre National de la Recherche Scientifique), Mikaël J. Pittet(University of Geneva), Jamie Wong(Alnylam Pharmaceuticals (United States)), Brett Marinelli(Cornell University)
Cited by 837
Related Papers
A clearer vision for in vivo imaging
|Nature Biotechnology|2001|3.8k
Inflammation in Atherosclerosis
|Arteriosclerosis Thrombosis and Vascular Biology|2012|3.7k
Transdermal drug delivery
|Nature Biotechnology|2008|3.4k
Physical and mechanical properties of PLA, and their functions in widespread applications — A comprehensive review
|Advanced Drug Delivery Reviews|2016|3.2k
Knocking down barriers: advances in siRNA delivery
|Nature Reviews Drug Discovery|2009|3.1k